Topics

"Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors" Drugs and Medication Database

22:16 EST 25th January 2020 | BioPortfolio

Here are the most relevant "Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors" Drugs and Medications that we have found in our database.

More Information about "Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors" on BioPortfolio

We have published hundreds of Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors news stories on BioPortfolio along with dozens of Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors Clinical Trials and PubMed Articles about Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors Companies in our database. You can also find out about relevant Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors Drugs and Medications on this site too.

Showing "Study ASP1948 Targeting Immune Modulatory Receptor Japanese Patients" Drugs and Medications, all 4

Possibly Relevant

Entereg [merck sharp & dohme corp.]

These highlights do not include all the information needed to use ENTEREG safely and effectively. See full prescribing information for ENTEREG. ENTEREG (alvimopan) capsules, for oral use Initial U.S. Approval: 2008

Prednisone [directrx]

PREDNISONE

Prednisone [directrx]

PREDNISONE

Sky-living water mt activition liquid [wings biomedical technology co., ltd.]

Drug fact



Quick Search